OpGen Inc (OPGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OpGen Inc (OPGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7102
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, swift detection and analysis of antibiotic resistance, and detection of pathogens in blood cultures. OpGen’s develops products that includes QuickFISH, and PNA FISH products, Acuitas products, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc (OPGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OpGen Inc, Medical Equipment, Deal Details 12
Venture Financing 12
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
Partnerships 21
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
Equity Offering 25
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
Debt Offering 33
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
Acquisition 35
OpGen Acquires AdvanDx 35
OpGen Inc – Key Competitors 36
OpGen Inc – Key Employees 37
OpGen Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 39
Financial Announcements 39
Aug 02, 2018: Opgen announces second quarter 2018 financial results 39
May 08, 2018: OpGen Announces First Quarter 2018 Financial Results 41
Mar 15, 2018: OpGen Announces Fourth Quarter and Full Year 2017 Financial Results 43
Nov 07, 2017: OpGen Reports 2017 Third Quarter Financial Results and Provides Business Update 45
Aug 08, 2017: OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update 47
Apr 26, 2017: OpGen Announces 2017 First Quarter Financial Results 49
Mar 23, 2017: OpGen Announces 2016 Fourth Quarter and Year End Financial Results 50
Jan 26, 2017: OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results 51
Corporate Communications 53
Apr 27, 2017: OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors 53
Legal and Regulatory 54
Feb 05, 2018: OpGen Regains Compliance With Nasdaq Listing Requirements 54
Product News 55
Feb 01, 2018: OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies 55
Apr 12, 2017: OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 56
Feb 14, 2017: OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting 58
Other Significant Developments 59
Mar 13, 2018: OpGen Announces Collaborator in Verification Study for Acuitas Test 59
Feb 13, 2018: OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas Tests 60
Jun 15, 2017: OpGen’s Acuitas Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
OpGen Inc, Medical Equipment, Key Facts, 2017 2
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Deals By Market, 2012 to YTD 2018 9
OpGen Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
AdvanDx Raises USD2.5 Million in Venture Financing 12
OpGen Raises USD1.2 Million in Venture Financing 13
Opgen Raises USD1 Million in Venture Financing 14
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 15
OpGen Raises US$2 Million In Venture Financing 16
AdvanDx Raises US$2 Million In Venture Financing 17
OpGen Raises Additional US$2.6 Million In Series C Financing 18
OpGen Raises Additional USD1.4 Million in Venture Financing 20
OpGen Enters into Research Agreement with Merck 21
OpGen Enters into Co-Development Agreement with Fluidigm 22
OpGen Enters Into Agreement With Applied Maths To Develop Whole Genome Mapping Software 23
OpGen Enters Into Co-Development Agreement With In-Q-Tel 24
OpGen Raises USD12 Million in Public Offering of Units 25
Opgen Raises USD10 Million in Public Offering of Units 27
OpGen to Raise upto USD11.5 Million in Public Offering of Shares 28
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 29
OpGen Raises USD17 Million in IPO 31
OpGen Raises USD0.5 Million in Debt Financing 33
OpGen Raises USD1.5 Million in Private Placement of 8% Notes 34
OpGen Acquires AdvanDx 35
OpGen Inc, Key Competitors 36
OpGen Inc, Key Employees 37
OpGen Inc, Subsidiaries 38

List of Figures
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OpGen Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OpGen Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OpGen Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OpGen Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[OpGen Inc (OPGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UroGen Pharma Ltd (URGN)-製薬・医療分野:企業M&A・提携分析
    Summary UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladd …
  • Investec Private Bank (South Africa):企業の戦略・SWOT・財務情報
    Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (South Africa) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • Fidelity Bank Plc:企業の戦略・SWOT・財務情報
    Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Angle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Agriterra Ltd (AGTA):企業の財務・戦略的SWOT分析
    Summary Agriterra Ltd (Agriterra) is a provider of agricultural investment and sustainable development solutions. The company provide products such as beef, maize, cocoa and palm oil. It offers business in the fields of beef that conducts cattle ranching, feedlot, abattoir operations and retail unit …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析
    Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NuStar GP Holdings LLC (NSH):企業の財務・戦略的SWOT分析
    Summary NuStar GP Holdings LLC (NuStar) is an oil and gas company that offers transportation and logistics services to petroleum products and anhydrous ammonia. The company offers services such as terminalling and storage of petroleum products, petroleum refining and marketing, and transportation of …
  • Zavante Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investi …
  • Mizuho Trust & Banking Co Ltd:戦略・SWOT・企業財務分析
    Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Mizuho Trust & Banking Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cosumar SA:戦略・SWOT・企業財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a technology company that offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, memory repair, wafer marking, laser ablati …
  • Cosmo Pharmaceuticals NV (COPN):医療機器:M&Aディール及び事業提携情報
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • SunTrust Banks Inc:企業のM&A・事業提携・投資動向
    SunTrust Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SunTrust Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • E.ON SE:発電所・企業SWOT分析
    E.ON SE - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abeome Corp-製薬・医療分野:企業M&A・提携分析
    Summary Abeome Corp (Abeome) is a biotechnology company that discovers diagnostic monoclonal antibodies and therapeutic antibodies. The company's pipeline components include PCSK9 to treat hypercholesterolemia; IL-17A to treat psoriasis and inflammation diseases, IL-17F to treat autoimmune diseases, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆